Product
RGB-14-P
1 clinical trial
1 indication
Indication
OsteoporosisClinical trial
A Randomised, Double Blind, Multicentre Phase III Study to Assess the Efficacy and Safety of RGB-14-P Compared to Prolia® in Women With Postmenopausal OsteoporosisStatus: Completed, Estimated PCD: 2023-10-02